In vitro inactivation of SARS-CoV-2 with 0.5% povidone iodine nasal spray (Nasodine) at clinically relevant concentrations and timeframes using tissue culture and PCR based assays
S. P. Tucker, S. Goodall, P. Molloy, J. Julander, M. Mendenhall, P. Friedland
This study evaluates the in vitro efficacy of 0.5% povidone iodine nasal spray against SARS-CoV-2, showing rapid inactivation of culturable virus but not PCR-detectable RNA.
bioRxiv · Jan 31, 2021 · PreprintMicrobiology